title: AQP1 in red blood cells of uremic patients during hemodialytic treatment.
abstract: Hemodialysis influences the transport of water through the erythrocytic membrane, and induces morphologic and functional modifications. Recently water channels, called aquaporins (AQP), have been identified on the membrane of red blood cells. The aim of the present study was, therefore, to evaluate any relationships between volumetric changes in erythrocytes (MCV), plasma osmolarity and membrane expression of AQP1 in 22 uremic patients during a hemodialysis session, and compare value with those in a control group of 22 healthy volunteers. Membranal AQP1 expression was evaluated using three methods: indirect immunofluorescence under confocal microscopy, immunoenzymatic method after membrane extraction, and immunoblotting. In uremic subjects, at baseline membrane AQP1 expression was significantly lower, whereas plasma osmolality was higher than in controls. At 1 and 2 h of replacement therapy, a progressive increase was observed in erythrocytic AQP1, values similar to those in controls being attained after 3.5 h. During the session osmolality values reduced progressively, becoming significantly lower than basal values. The mean erythrocytic corpuscular volume in patients with ESRD was significantly lower than in cntrols at baseline. This value increased during hemodialysis, attaining statistical significance with respect to the basal value at 3.5 h of dialysis. Close correlations were found between plasma osmolality and AQP1 values (r = -0.930; p < 0.05), and also between MCV and plasma osmolality trend (r = -0.909; p < 0.05). There was a linear correlation (r = 0.63, p < 0.05) between plasma AVP concentrations and plasma osmolality. The variations found in plasma osmolarity during hemodialysis, may induce AQP1 expression on the membrane of intact red blood cells.
authors.affiliation: Department of Internal Medicine, University of Messina, Italy. Buemim@Unime.it/Asrael@worldmailer.com
authors.forename: M
authors.initials: M
authors.lastname: Buemi
authors.forename: F
authors.initials: F
authors.lastname: Floccari
authors.forename: G
authors.initials: G
authors.lastname: Di Pasquale
authors.forename: G
authors.initials: G
authors.lastname: Cutroneo
authors.forename: A
authors.initials: A
authors.lastname: Sturiale
authors.forename: C
authors.initials: C
authors.lastname: Aloisi
authors.forename: A
authors.initials: A
authors.lastname: Ruello
authors.forename: A
authors.initials: A
authors.lastname: Romeo
authors.forename: A
authors.initials: A
authors.lastname: Favaloro
authors.forename: F
authors.initials: F
authors.lastname: Corica
authors.forename: N
authors.initials: N
authors.lastname: Frisina
authors.forename: G
authors.initials: G
authors.lastname: Anastasi
mesh_terms: D000328:Adult; D000368:Aged; D051398:Aquaporin 1; D020346:Aquaporins / Q000097:blood*; D001789:Blood Group Antigens; D001794:Blood Pressure; D004909:Erythrocyte Indices; D004912:Erythrocytes / Q000166:cytology / Q000378:metabolism*; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis; D012964:Sodium / Q000097:blood; D014511:Uremia / Q000097:blood* / Q000628:therapy; D014667:Vasopressins / Q000097:blood
chemical_list: C496020:AQP1 protein, human; D020346:Aquaporins; D001789:Blood Group Antigens; D006454:Hemoglobins; D014667:Vasopressins; D051398:Aquaporin 1; D012964:Sodium; D011188:Potassium